Orchid Pharma Ltd. (ORCHPHARMA): Orchid Pharma Share Price jumps 4.21% near 52-week high on Rs 1,127 trade; market cap at Rs 5,923.25 crore

Orchid Pharma Share Price is trading at Rs 1,127, up 4.21% today, and remains close to its 52-week high while the market capitalisation stands at Rs 5,923.25 crore. Orchid Pharma Ltd. (ORCHPHARMA) is drawing attention because the latest Univest figures place the stock near its yearly high even as the broader move still needs to be read with the company’s valuation and financial snapshot. The stock opened at Rs 1,087.75, moved between Rs 1,073.75 and Rs 1,142.65, and last traded above the previous close of Rs 1,081.45. For readers tracking Orchid Pharma Share Price Today, the key point is simple: the price event is verified, but the numbers alone do not establish a company-specific catalyst.

The latest Univest data also places Orchid Pharma Stock News in a broader market context. The company’s P/E of 747.32, P/B of 4.13, EPS of 1.45, book value of Rs 261.65 and dividend yield of 0 create a sharply mixed valuation picture, while revenue for Jun 2026 stood at Rs 3,041.71 crore. The near-52-week-high move therefore combines price action with a demanding valuation setup, making Orchid Pharma Share Price worth tracking for Indian Stock Market readers watching 52 Week High Stocks and Share Market Today themes.

Orchid Pharma Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 1,127
Previous Close	Rs 1,081.45
Today's Move	+Rs 45.55 (+4.21%)
Open	Rs 1,087.75
High	Rs 1,142.65
Low	Rs 1,073.75
Turnover	Rs 2.28 crore
Market Capitalisation	Rs 5,923.25 crore

Orchid Pharma Ltd. (ORCHPHARMA) traded at Rs 1,127 versus the previous close of Rs 1,081.45, a rise of 4.21%. The stock opened at Rs 1,087.75, reached a high of Rs 1,142.65 and touched a low of Rs 1,073.75.

Orchid Pharma Share Price today shows a clear intraday gain of Rs 45.55 over the previous close of Rs 1,081.45, with the stock last traded at Rs 1,127. The move of 4.21% came after an open of Rs 1,087.75 and within an intraday range of Rs 1,073.75 to Rs 1,142.65. That keeps the stock trading close to its 52-week high and gives readers a precise view of Orchid Pharma Share Price Today rather than a broad market label.

Turnover stood at Rs 2.28 crore, which is the traded value attached to the move. The latest Univest figures confirm that the stock is within the near-52-week-high event zone, but they do not identify a company-specific trigger. For Orchid Pharma Stock News and Orchid Pharma Share News readers, the verified takeaway is that price action is the main event on display, while the data confirms the move without assigning a cause. That sets up the question of whether the valuation backdrop supports the current Orchid Pharma Share Price level.

Orchid Pharma Ltd. (ORCHPHARMA) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 5,923.25 crore
P/E Ratio	747.32x
P/B Ratio	4.13x
ROE	0.7%
ROCE	1.11%
EPS	Rs 1.45
Book Value Per Share	Rs 261.65
Dividend Yield	0%

Orchid Pharma Ltd. (ORCHPHARMA) fundamental metrics show P/E 747.32x, P/B 4.13x, ROE 0.7%, ROCE 1.11%. These figures provide context only and are not a buy or sell signal.

Orchid Pharma Ltd. has a market capitalisation of Rs 5923.25 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 747.32x, P/B at 4.13x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 0.7% and ROCE of 1.11%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 1.45, book value per share of Rs 261.65, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.52x, median ROE of 11.78%, median ROCE of 13.65%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	747.32x
Benchmark Median P/E	28.52x
Benchmark Average P/E	38.29x
Benchmark P/E Range	0x to 421.02x
Company P/B Ratio	4.13x
Benchmark Median P/B	2.96x
Company ROE	0.7%
Benchmark Median ROE	11.78%
Company ROCE	1.11%
Benchmark Median ROCE	13.65%
Company Market Capitalisation	Rs 5,923.25 crore
Benchmark Median Market Cap	Rs 729.99 crore

Orchid Pharma Ltd. (ORCHPHARMA) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Orchid Pharma Ltd. (ORCHPHARMA) has a P/E ratio of 747.32x, which is above the benchmark median of 28.52x, a difference of +2,520.34%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Orchid Pharma Ltd. (ORCHPHARMA) has a ROE of 0.7%, which is below the benchmark median of 11.78%, a difference of -94.06%. Orchid Pharma Ltd. (ORCHPHARMA) has a ROCE of 1.11%, which is below the benchmark median of 13.65%, a difference of -91.87%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
IOL Chemicals And Pharmaceuticals Ltd.	IOLCP	5,957.14	35.47	3.2	7.9	10.65
FDC Ltd.	FDC	5,746.38	20.18	2.26	11.81	15.93
SENORES PHARMACEUTICALS L	SENORES	6,474.21	50.69	6.65	14.14	15.66
Gujarat Themis Biosyn Ltd.	GUJTHEM	5,393.49	110.78	5.14	17.41	18.16
Morepen Laboratories Ltd.	MOREPENLAB	6,624.76	47.71	5.15	7.96	10.19

Orchid Pharma Ltd. (ORCHPHARMA) has a P/E ratio of 747.32x compared with the displayed peer median of 47.71x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 0.7% compares with a peer median of 11.81% across the companies shown in the table. ROCE stood at 1.11% versus the displayed peer median of 15.66%, providing a capital-efficiency comparison. Orchid Pharma Ltd. (ORCHPHARMA) has a market capitalisation of Rs 5,923.25 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

Why Investors Are Watching Orchid Pharma

• Orchid Pharma Share Price is trading at Rs 1,127, up 4.21% from the previous close of Rs 1,081.45.
• The stock is moving near its 52-week high, which keeps Orchid Pharma Share Price Today in focus.
• P/E is 747.32 and P/B is 4.13, which makes Orchid Pharma Stock Analysis heavily valuation-sensitive.
• ROE is 0.7 and ROCE is 1.11, both below the same-industry medians in the benchmark set.
• Market capitalisation is Rs 5,923.25 crore, and revenue for Jun 2026 stood at Rs 3,041.71 crore.

About Orchid Pharma

Orchid Pharma Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. The latest Univest figures place Orchid Pharma Share Price within a near-52-week-high event, while company-level financials show revenue, earnings, EPS and book value data that help readers place the stock in context. Orchid Pharma Share Price Today is therefore best read alongside the company’s valuation and sector positioning rather than in isolation. For Orchid Pharma Stock News readers, the core profile is defined by its listed-company metrics, not by any unsupported business narrative.

Frequently Asked Questions

Why is Orchid Pharma Share Price in focus today?

Ans. Orchid Pharma Share Price is in focus because it traded at Rs 1,127, up 4.21% from the previous close, while staying close to its 52-week high. The move is verified by the latest Univest figures.

What is Orchid Pharma Share Price today?

Ans. Orchid Pharma Share Price today is Rs 1,127. It moved up Rs 45.55 from the previous close of Rs 1,081.45 and traded within an intraday range of Rs 1,073.75 to Rs 1,142.65.

How close is Orchid Pharma to its 52-week high?

Ans. Orchid Pharma Share Price is trading near its 52-week high, which is the event that triggered this report. The latest figures show the stock remained close to that yearly peak during the current market move.

What is Orchid Pharma’s market capitalisation?

Ans. Orchid Pharma’s market capitalisation stands at Rs 5,923.25 crore. That places Orchid Pharma Share Price above the median market cap of the same-industry benchmark set, which is Rs 729.99 crore.

What does Orchid Pharma Fundamental Analysis show?

Ans. Orchid Pharma Fundamental Analysis shows a high P/E of 747.32, P/B of 4.13, ROE of 0.7 and ROCE of 1.11. EPS is 1.45, book value is Rs 261.65 and dividend yield is 0.

How does Orchid Pharma compare with its industry benchmark?

Ans. Orchid Pharma Share Price sits in a sector where the industry benchmark median P/E is 28.52. Its P/E of 747.32 is well above that, while its ROE and ROCE are below the industry medians.

Which peer is closest to Orchid Pharma by market cap?

Ans. Among the listed peers, IOL Chemicals And Pharmaceuticals Ltd. at Rs 5,957.14 crore and FDC Ltd. at Rs 5,746.38 crore are closest in market capitalisation to Orchid Pharma Share Price and its Rs 5,923.25 crore market cap.

Where can I track Orchid Pharma Share Price and stock news?

Ans. Readers can track Orchid Pharma Share Price, Orchid Pharma Share Price Today, Orchid Pharma Stock News and key ratios on Univest. The stock page also covers market cap, valuation, EPS, book value and sector context.

Track Orchid Pharma Share Price on Univest

Use Orchid Pharma Ltd. (ORCHPHARMA) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.

On Univest, readers can track Orchid Pharma Share Price Live alongside market capitalisation, P/E ratio, P/B ratio, EPS, book value, dividend yield, 52-week levels and recent price updates. Univest also brings together Orchid Pharma Stock News, Orchid Pharma Latest News and Orchid Pharma Fundamental Analysis in one place for faster reading. If you follow Orchid Pharma Share Price Update closely, Univest provides the same stock page reference used for this report.